| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 10/16/2007 | CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 10/11/2007 | WO2007114526A1 Process for producing high-purity prasugrel and acid addition salt thereof |
| 10/11/2007 | WO2007114323A1 Aminopyrrolidine compound |
| 10/11/2007 | WO2007113575A2 Reagents and methods for cross-linking biological molecules |
| 10/11/2007 | WO2007113290A1 Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones |
| 10/11/2007 | WO2007054750A3 Process for the preparation of olanzapine |
| 10/11/2007 | US20070238783 Beta-benzyloxyaspartate derivatives with amino group on benzene ring |
| 10/11/2007 | US20070238763 Urea derivatives as integrin a4 antagonists |
| 10/11/2007 | US20070238741 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine |
| 10/11/2007 | CA2648503A1 Method for producing high-purity prasugrel or an acid addition salt thereof |
| 10/11/2007 | CA2646090A1 Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones |
| 10/10/2007 | EP1843410A2 Functionalized heteroacenes and electronic devices generated therefrom |
| 10/10/2007 | EP1841774A1 PROCESS FOR PREPARING 5,6-DIHYDRO-4-(S)-(ETHYLAMINO)-6-(S) METHYL-4H-THIENOÝ2,3b¨THIOPYRAN-2-SULPHONAMIDE-7,7-DIOXIDE HCI |
| 10/10/2007 | EP1841773A2 Derivatized 3,4-alkylenedioxythiophene monomers, methods of making them, and use thereof |
| 10/10/2007 | EP1841756A1 3-heterocyclyl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 10/10/2007 | EP1776369B1 Thienopyridone carboxamides and their medical use |
| 10/10/2007 | EP1723141A4 Industrial process for preparation of clopidogrel hydrogen sulphate |
| 10/10/2007 | EP1587809B1 Thienopyridazinone derivative as modulators of autoimmune diseases |
| 10/10/2007 | EP1490058B1 Peroxisome proliferator activated receptor modulators |
| 10/10/2007 | EP1381608B1 Cyclohexylphenyl vasopressin agonists |
| 10/10/2007 | EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist |
| 10/10/2007 | EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 10/10/2007 | EP0944633B1 Substituted phenylketoenols and their use as pesticides and herbicides |
| 10/09/2007 | US7279490 Ophthalmic compositions for treating ocular hypertension |
| 10/09/2007 | US7279469 Diaminotriazoles useful as inhibitors of protein kinases |
| 10/06/2007 | CA2583053A1 Functionalized heteroacenes and electronic devices generated therefrom |
| 10/04/2007 | WO2007054831A3 Inhibitors of vegf receptor and hgf receptor signaling |
| 10/04/2007 | US20070232812 optical, electro-optical, electronic devices liquid crystal displays, optical films, organic field effect transistors; integrated circuits |
| 10/04/2007 | US20070232811 Sterically hindered pi-bridge nonlinear optical chromophores, processes including same, and devices therefrom |
| 10/04/2007 | US20070232799 PROCESS FOR PREPARING 6-ARYL-4H-S-TRIAZOLO[3,4-c]-THIENO[2,3-e]-1,4-DIAZEPINES |
| 10/04/2007 | US20070232662 Indol-2-One Derivatives for the Treatment of Central Nervous Disorders, Gastrointestinal Disorders and Cardiovascular Disorders |
| 10/03/2007 | EP1839659A2 Chemicals compounds |
| 10/03/2007 | EP1838717A2 Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same |
| 10/03/2007 | EP1838716A1 Olanzapine pamoate dihydrate |
| 10/03/2007 | EP1490361B1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 10/03/2007 | CN101048413A Thienopyridines as allosteric potentiators of the M4 muscarinic receptor |
| 10/03/2007 | CN101048412A Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
| 10/03/2007 | CN101048403A Heterocyclic antiviral compounds |
| 10/03/2007 | CN101048390A Heterocyclical chromophore architectures |
| 10/03/2007 | CN101045731A S-type clopidogrel and preparation method of its salt |
| 10/02/2007 | US7276592 Nucleotide analogs with six-membered rings |
| 10/02/2007 | US7276532 Incontinence |
| 10/02/2007 | US7276524 Compounds as antumor agents or immunosuppressants |
| 10/02/2007 | US7276519 Anticancer agents; osteoporosis; polycystic kidney disease; antiarthritic agents; organ transplant rejection |
| 10/02/2007 | US7276517 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase |
| 10/02/2007 | US7276511 E.g., N-{2-(3,4-dichlorophenyl)-2-[(3,3-diphenylpropionyl)-methylamino]-4-{spiro[benzo(c)thiophene-1(3H),4'-piperidine]-(2S)-oxide}-1'-yl-butyl}-3,3,3-trifluoro-N-methyl-propionamide hydrochloride, NK-1 or NK-2 receptor antagonists; used to treat irritable bowel syndrome, pain, anxiety and vomiting |
| 10/02/2007 | CA2352520C Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives |
| 10/02/2007 | CA2289509C Novel compounds |
| 09/27/2007 | WO2007108615A1 Method for preparing clopidogrel 1,5-naphthalenedisulfonate or hydrate thereof |
| 09/27/2007 | WO2007107005A1 Inhibitors of protein tyrosine kinase activity |
| 09/27/2007 | WO2007025009A3 Indenoisoquinolinone analogs and methods of use thereof |
| 09/27/2007 | US20070225528 Process for Producing Optically Active Alcohol |
| 09/27/2007 | US20070225167 2-Ethyl-4,6-Dimethyl-Phenyl-Substituted Tetramic Acid Derivatives as Pest Control Agents and/or Herbicides |
| 09/27/2007 | CA2645546A1 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases |
| 09/26/2007 | EP1837337A1 Novel crystalline polymorphs of clopidogrel |
| 09/26/2007 | EP1836203A2 Heteroaryl substituted quinolin-4-ylamine analogues |
| 09/26/2007 | EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/26/2007 | EP1383750B1 Urea derivatives as integrin alpha 4 antagonists |
| 09/26/2007 | CN100339352C 2-and 2,5-substituted phenylketoenols |
| 09/25/2007 | US7273876 Substituted bicylic thiophene derivatives, compositions containing such compounds and methods of use |
| 09/25/2007 | CA2269815C Thienopyrimidines having pde v-inhibiting action |
| 09/20/2007 | WO2007105638A1 Process for production of fused ring compound |
| 09/20/2007 | WO2007105386A1 Fused ring compound and method for producing same, polymer, organic thin film containing those, and organic thin film device and organic thin film transistor comprising such organic thin film |
| 09/20/2007 | WO2007105154A2 Antibiotic compounds |
| 09/20/2007 | WO2007104558A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors) |
| 09/20/2007 | WO2007084560A3 INHIBITORS OF TNFα, PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH |
| 09/20/2007 | WO2007081517A8 Anti-viral compounds |
| 09/20/2007 | US20070219234 Thienopyridine Derivatives |
| 09/20/2007 | US20070219197 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives |
| 09/20/2007 | US20070219166 Stereoselective Method for the Production of Clopidogrel |
| 09/20/2007 | US20070215839 Class of molecular actuators where bulk actuation mechanisms such as ion intercalation are enhanced by controllable single molecule conformational rearrangements offers promise in exhibiting large active strains at moderate stresses |
| 09/20/2007 | CA2646516A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors) |
| 09/20/2007 | CA2643962A1 Antibiotic compounds |
| 09/19/2007 | EP1834954A1 Thiazoles as NF-kB Inhibitors (proteasome inhibitors) |
| 09/19/2007 | EP1833834A1 New compounds |
| 09/19/2007 | EP1833797A1 Azacyclic compounds as inhbitors of sensory neurone specific channels (sns) |
| 09/19/2007 | EP1642896B1 Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers |
| 09/19/2007 | EP1515975B1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/19/2007 | EP1513845B1 A process for the preparation of olanzapine and an intermediate therefor |
| 09/19/2007 | EP1157027B1 Heterocyclic metallocene compounds and use thereof in catalyst systems for producing olefin polymers |
| 09/19/2007 | CN101039908A Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 09/19/2007 | CN100338070C Method for the decarboxylation of dicarboxylic acids |
| 09/19/2007 | CN100338069C Process for the preparation of olanzapine and an intermediate therefor |
| 09/19/2007 | CN100338068C Process for preparing clopidogrel |
| 09/18/2007 | US7271264 Pentacyclic oxepines and derivatives thereof, compositions and methods |
| 09/18/2007 | US7271179 Inhibitors of JAK protein kinase |
| 09/18/2007 | US7271176 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/13/2007 | WO2007102679A1 Novel thienopyrimidine derivatives or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same |
| 09/13/2007 | WO2007102574A1 Photochromic compound |
| 09/13/2007 | WO2007102167A1 A process for the preparation of anhydrous polymorphic form of olanzapine |
| 09/13/2007 | US20070213362 2-nh-heteroarylimidazoles with antibacterial activity |
| 09/13/2007 | US20070213360 Tetrahydropyridothiophenes for Use in the Treatment of Cancer |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | CA2644996A1 A2a adenosine receptor antagonists |
| 09/13/2007 | CA2640242A1 A process for the preparation of polymorph form i of (s)-(+)-methyl-a-(2-chlorophenyl)-6,7-dyhidro-thieno-[3,2-c]pyridine-5(4h)-acetate hydrogen sulfate |
| 09/12/2007 | EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 09/12/2007 | EP1831229A1 Thienopyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 09/12/2007 | EP1831228A1 Novel pyrazole derivatives and their use as modulators of nicotinic acetylcholine receptors |
| 09/12/2007 | EP1831227A2 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |